Safety and Efficiency of Trabectome-mediated Trabecular Meshwork Ablation for Chinese Glaucoma Patients: A Two-year, Retrospective, Multicentre Study / 中华医学杂志(英文版)
Chinese Medical Journal
;
(24): 420-425, 2018.
Article
in English
| WPRIM
| ID: wpr-342022
ABSTRACT
<p><b>Background</b>The aim of the study was to evaluate the long-term safety and efficacy of the Trabectome for Chinese glaucoma patients.</p><p><b>Methods</b>This was a multicenter, retrospective, observational study. Glaucoma patients, except those with neovascular glaucoma, with/without a visually significant cataract were enrolled. The patients received Trabectome or a combined surgery with phacoemulsification and intraocular lens implantation. The primary outcome evaluation was a reduction in intraocular pressure (IOP), and the secondary outcomes were a reduction in glaucoma medication, the 2-year success percentages, and complications. Success was defined as an IOP <21 mmHg and at least a 20% IOP reduction from baseline after 3 months for any two consecutive visits, without additional glaucoma surgery. The data were processed using the R Stats Package version 3.0.0. The Wilcoxon test was used to compare the postoperative IOP and the number of glaucoma medications with baselines. The Kaplan-Meier test was used to calculate the 2-year success percentage. The risk factors related to Trabectome failure were determined by logistic regression.</p><p><b>Results</b>A total of 120 glaucoma patients were enrolled. The Trabectome efficiently reduced the IOP from a baseline of 22.8 ± 1.34 mmHg to 17.6 ± 0.96 mmHg, and the use of glaucoma medications from 2.2 ± 0.17 mmHg to 1.4 ± 0.21 in a 2-year follow-up (both, P < 0.01). The overall success percentage was 80%. No risk factor related to Trabectome failure was identified. No vision-threatening complication was observed. Ten patients, who required secondary glaucoma surgery, all reached the target IOP.</p><p><b>Conclusions</b>In a 2-year follow-up, Trabectome was an efficient and safe procedure for Chinese glaucoma patients.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
/
Observational study
/
Prognostic study
/
Risk factors
Language:
English
Journal:
Chinese Medical Journal
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS